Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group
| Image |  |
|---|---|
| Description | |
| Author/s |
author: Christos K. Kontos Argiris Symeonidis Eleftheria Hatzimichael Panagiotis T Diamantopoulos |
| Publication date | July 7, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |